Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.verified

FENC

Price:

$6.1455

Market Cap:

$168.56M

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.[Read more]

Industry

Biotechnology

IPO Date

2017-09-15

Stock Exchange

NASDAQ

Ticker

FENC

The PE Ratio as of December 2024 (TTM) for Fennec Pharmaceuticals Inc. (FENC) is -153.64

According to Fennec Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -153.64. This represents a change of 1.64% compared to the average of -8.82 of the last 4 quarters.

Fennec Pharmaceuticals Inc. (FENC) Historical PE Ratio (quarterly & annually)

How has FENC PE Ratio performed in the past?

The mean historical PE Ratio of Fennec Pharmaceuticals Inc. over the last ten years is -13.96. The current -153.64 PE Ratio has changed 109.93% with respect to the historical average. Over the past ten years (40 quarters), FENC's PE Ratio was at its highest in in the March 2015 quarter at 36.40. The PE Ratio was at its lowest in in the September 2015 quarter at -44.65.

Quarterly (TTM)
Annual

Average

-13.96

Median

-11.28

Minimum

-28.66

Maximum

-6.56

Fennec Pharmaceuticals Inc. (FENC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Fennec Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 134.84%

Maximum Annual PE Ratio = -6.56

Minimum Annual Increase = -174.97%

Minimum Annual PE Ratio = -28.66

Quarterly (TTM)
Annual
YearPE RatioChange
2023-18.5882.99%
2022-10.1554.92%
2021-6.56-33.47%
2020-9.85-4.92%
2019-10.36-15.21%
2018-12.22-42.67%
2017-21.32119.32%
2016-9.72-66.08%
2015-28.66134.84%
2014-12.20-174.97%

Fennec Pharmaceuticals Inc. (FENC) Average PE Ratio

How has FENC PE Ratio performed in the past?

The current PE Ratio of Fennec Pharmaceuticals Inc. (FENC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-11.76

5-year avg

-11.10

10-year avg

-13.96

Fennec Pharmaceuticals Inc. (FENC) PE Ratio vs. Peers

How is FENC’s PE Ratio compared to its peers?

Fennec Pharmaceuticals Inc.’s PE Ratio is less than Molecular Partners AG (-2.46), less than MediciNova, Inc. (-0.04), less than Anebulo Pharmaceuticals, Inc. (-3.86), greater than Champions Oncology, Inc. (-189.98), less than Cyteir Therapeutics, Inc. (-9.12), less than Keros Therapeutics, Inc. (-3.34), less than Janux Therapeutics, Inc. (-50.83), less than Edgewise Therapeutics, Inc. (-22.57), less than Harmony Biosciences Holdings, Inc. (15.84), less than Ikena Oncology, Inc. (0), less than Aerovate Therapeutics, Inc. (-1.27), less than Eliem Therapeutics, Inc. (-0.88), less than Decibel Therapeutics, Inc. (0), less than Olema Pharmaceuticals, Inc. (-1.95), less than Disc Medicine, Inc. (-2.94), less than Larimar Therapeutics, Inc. (-18.90), less than Orchestra BioMed Holdings, Inc. (-3.76), less than null (-3.12),

Build a custom stock screener for Fennec Pharmaceuticals Inc. (FENC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fennec Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fennec Pharmaceuticals Inc. (FENC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fennec Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Fennec Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Fennec Pharmaceuticals Inc. (FENC)?

What is the highest PE Ratio for Fennec Pharmaceuticals Inc. (FENC)?

What is the 3-year average PE Ratio for Fennec Pharmaceuticals Inc. (FENC)?

What is the 5-year average PE Ratio for Fennec Pharmaceuticals Inc. (FENC)?

How does the current PE Ratio for Fennec Pharmaceuticals Inc. (FENC) compare to its historical average?